Christy P Brown

The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study.

R. Zuwallack, B. Make, N. Hanania, 2005, Clinical therapeutics.

Efficacy of Advair Diskus 250/50 (Fluticasone Propionate/Salmeterol) in Patients Previously Naïve to COPD Maintenance Therapy

A. Anzueto, J. Yates, K. Knobil, 2004 .

Efficacy of Advair Diskus 250/50 (Fluticasone Propionate/Salmeterol) or Ipratropium/Albuterol in Patients with COPD Associated with Chronic Bronchitis and/or Emphysema

F. Sciurba, A. Emmett, C. Kalberg, 2004 .

Management of chronic obstructive pulmonary disease associated with chronic bronchitis with inhaled fluticasone propionate/salmeterol (ADVAIR DISKUS) 250/50: results of a patient experience trial.

S. Stoloff, S. Samuels, D. Kerney, 2006, MedGenMed : Medscape general medicine.